Man­u­fac­tur­ing roundup: Eu­roAPI to in­vest $50M+ in Hun­gary site; WuXi to ex­pand Ger­man fa­cil­i­ty

Ac­tive phar­ma­ceu­ti­cal in­gre­di­ent man­u­fac­tur­er Eu­roAPI is look­ing to make a €50 mil­lion ($53.4 mil­lion) in­vest­ment in­to boost­ing pro­duc­tion at its fa­cil­i­ty in Bu­dapest, Hun­gary.

Ac­cord­ing to a re­lease, Eu­roAPI’s ex­pan­sion plans to “de­bot­tle­neck” the pro­duc­tion at the fa­cil­i­ty along with dou­bling the fa­cil­i­ty’s out­put of prostaglandin by 2027. Prostaglandin is a lipid used in the pro­duc­tion of APIs. The project al­so aims to bol­ster the man­u­fac­tur­er’s op­er­a­tions in Hun­gary.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER